top of page
Prior Speakers
James Allison
2018 Nobel Laureate
Dr. Robert Weinberg
Wolf Prize Awardee, Daniel K. Ludwig Professor for Cancer Research at Whitehead Institute
Dr. Ronald DePinho
President, MD Anderson Cancer Center
Isaac Blech
HNW Biotech Investor
Dr. Irving Weissman
Director of the Stanford Institute of Stem Cell Biology and Regenerative Medicine
Dennis Purcell
Founder of Aisling Capital
Phil Ross
Global Head of Healthcare Banking - JP Morgan
Francesca Bosetti
Director, Stroke Program, National Institute of Neurological Disorders and Stroke
Greg Simon
President, Biden Cancer Initiative
Bill Doyle
CEO Novocure, Frm Head Licensing of at J&J
Dr. Roy Herbst
Chief Medical Oncology - Yale Cancer Center
Christiana Bardon
Partner, MPM Capital
Brian Leyland-Jones
Former Director of the Emory and McGill Cancer Centers
Fred Frank
Noted HC Banker - Vice Chair, Barclays, Smith Barney, Lehman, Burill, EVOLUTION
Dr. Andrew Lo
Director of MIT's Laboratory for Financial Engineering
Alfred Slanetz
CEO, Bluebird Bio | Frm Head of Product Development, Genetech
David Schlotterbeck
Frm Vice Chairman Cardinal Health / CEO & Chair Carefusion
Keith Flaherty
Founder, Loxo Oncology | Director of Clinical Research, Mass General Cancer Center
Reiner Brentjins
Director of Cellular Therapies, Memorial Sloan
George Poste
Former Head of R&D, GSK
Robert Gallo
Founder, HIV/AIDS
Manny Villafana
Founder, St. Jude Medical
Ronan O'Hagan
Director Oncology Drug Development, Merck
Raju Kucherlapati
Founder Millennium Pharma and Professor Genetics, Harvard
Abe Heifets
CEO, Atomwise
bottom of page